Hummingbird Bioscience Archives

George Clinical Selected as CRO for Hummingbird Bioscience’s Phase 1 Oncology Trials in Australia

SYDNEY, May 4 (Korea Bizwire) — George Clinical announces that the company has initiated preparations in Australia for two oncology Phase 1b trials that will examine a Hummingbird Bioscience precision therapy program targeting HER3, a potent driver of tumor growth and resistance against cancer drugs, in biomarker-selected patient populations, including lung cancer. George Clinical is [...]

SK Holdings Invests in Singapore’s Hummingbird Bioscience

SEOUL, May 11 (Korea Bizwire) — SK Holdings Co., the holding firm of South Korean energy and telecoms conglomerate SK Group, said Monday it has invested in Singapore’s Hummingbird Bioscience in the latest move to secure technology for antibody-based medicines. SK Holdings said it has participated as a major investor in the investment worth about [...]